Pfizer

CellCentric wins $25m from Pfizer for cancer collaboration
Business Weekly
Wed, 07/12/23 - 09:39 am
Pfizer
CellCentric
cancer
inobrodib
Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech
Fierce Pharma
Tue, 07/11/23 - 11:32 pm
Moderna Therapeutics
COVID-19
vaccines
patents
Pfizer
BioNTech
legal
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Thu, 07/6/23 - 10:19 am
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
BioSpace
Wed, 07/5/23 - 11:44 am
Pfizer
Samsung BioLogics
drug manufacturing
biosimilars
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Motley Fool
Mon, 07/3/23 - 10:37 am
Pfizer
obesity
lotiglipron
danuglipron
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
Ex-Pfizer employee charged with insider trading over Covid treatment
FT.com
Thu, 06/29/23 - 11:00 pm
Pfizer
inside trading
Paxlovid
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
Pfizer-OPKO's growth hormone drug gets US approval in kids
Yahoo/Reuters
Wed, 06/28/23 - 10:04 am
Pfizer
OPKO Health
FDA
pediatric
growth hormone deficiency
Ngenla
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Novo Nordisk
hemophilia
clinical trials
Pfizer
Roche
Hemlibra
Pfizer's Litfulo Scores FDA Approval As First Alopecia Treatment For Adolescents
Yahoo/Benzinga
Tue, 06/27/23 - 10:15 am
Pfizer
FDA
Litfulo
alopecia areata
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Eli Lilly
obesity
orforglipron
Pfizer
Novo Nordisk
Mounjaro
Pfizer, citing safety concerns, scraps one of two obesity pill hopefuls
BioPharma Dive
Mon, 06/26/23 - 09:57 am
Pfizer
obesity
lotiglipron
danuglipron
Pfizer, GSK RSV shots get tepid recommendations from CDC advisory panel
Fierce Pharma
Thu, 06/22/23 - 10:19 am
RSV
GSK
Pfizer
vaccines
CDC
elderly
Pfizer's Talzenna snags broader prostate cancer nod than AstraZeneca and Merck's rival PARP med
Fierce Pharma
Thu, 06/22/23 - 10:12 am
Pfizer
FDA
prostate cancer
Talzenna
AstraZeneca
PARP inhibitors
Merck
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
EP Vantage
Wed, 06/21/23 - 10:38 am
ADA
Eli Lilly
Pfizer
diabetes
obesity
orforglipron
danuglipron
lotiglipron
Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec
BioSpace
Mon, 06/19/23 - 10:31 am
Eli Lilly
Emgality
Pfizer
Nurtec
migraines
Texas Orders Pfizer to Turn Over Meta Advertising Records
BioSpace
Thu, 06/15/23 - 10:13 am
Pfizer
legal
Meta
pharma advertising
Texas
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Thu, 06/15/23 - 09:58 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen

Pages